Table 1.
Patients’ clinicopathological characteristics and treatment details
| Characteristics | Primary cytoreduction | Secondary cytoreduction |
|---|---|---|
| All cases, n | 6 | 7 |
| Age, years median (range) | 55.4 (40–79) | 58.8 (49–73) |
| FIGO stage | ||
| III C | 4 | 5 |
| IV | 2 | 2 |
| Tumor histotype | ||
| Serous | 6 | 7 |
| Endometriod | 0 | 0 |
| Tumor grade | ||
| G1 | 0 | 0 |
| G2–3 | 6 | 7 |
| No residual tumor at primary debulking surgery | 6 | 5 |
| PFI-1, months, median (range) | 25 (4–36) | 23 (12–34) |
| Estimated blood loss, mL, median (range) | 200 (80–550) | 50 (30–200) |
| Operative time, min, median (range) | 509 (200–845) | 253 (90–380) |
| Hospital stay, days, median (range) | 9 (5–18) | 3 (2–5) |
| PFI-2, months, median (range) | NA | Median not reached |
FIGO International Federation of Gynecology and Obstetrics, PFI-1 primary platinum-free interval after primary cytoreductive surgery, PFI-2 primary platinum-free interval after secondary cytoreductive surgery